Sort   by:  
 Page size 
UnknownTreatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT).
Not available
S-EPMC8842149 | biostudies-literature
UnknownNivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).
Not available
S-EPMC6075826 | biostudies-literature
UnknownOutcomes and prognostic insights in primary tracheal cancer: a multicenter retrospective study.
Not available
S-EPMC12541878 | biostudies-literature
UnknownReal-World Testing Practices, Treatment Patterns and Clinical Outcomes in Patients from Central Eastern Europe with EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Retrospective Chart Review Study (REFLECT).
Not available
S-EPMC9406426 | biostudies-literature
UnknownNivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
Not available
S-EPMC7193684 | biostudies-literature
UnknownRET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy.
Not available
S-EPMC9657474 | biostudies-literature
UnknownTracheal Tumors: Clinical Practice Guidelines for Palliative Treatment and Follow-Up.
Not available
S-EPMC11445028 | biostudies-literature
UnknownUpdated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.
Not available
S-EPMC7932969 | biostudies-literature
UnknownFour-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis.
Not available
S-EPMC7193685 | biostudies-literature
UnknownNivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Not available
S-EPMC4681400 | biostudies-literature
Sort   by:  
 Page size